Lupin Pharma ties up with US firm
Facebook Twitter google+ RSS Feed

Lupin Pharma ties up with US firm

By siliconindia staff writer   |   Thursday, 27 January 2005, 08:00 Hrs
Printer Print Email Email
MUMBAI:Pharma major Lupin Ltd has tied up with Cornerstone BioPharma Inc.of US for marketing its anti-infective brand Cefixime Suprax.

Cornerstone's sales force will co-promote Suprax with a focus on primary care physicians, who were not covered by the company, the company said.

Suprax, developed by the Mumbai based Lupin, was approved in 2004 and has been promoted by Lupin Pharma Inc's pediatric focused sales force.

Lupin said the partnership represents a significant expansion in the scope of physician coverage for Suprax in the $1.2 billion oral suspension anti-infective market.

Write your comment now
Submit Reset